Skip to main content
Momina Krepost AD logo

Momina Krepost AD — Investor Relations & Filings

Ticker · MKR ISIN · BG11MOVEAT12 LEI · 8945008S9A7591B5GX71 BSOBGN Manufacturing
Open in API
Filings indexed 63 across all filing types
Latest filing 2026-04-29 Interim / Quarterly Rep…
Country BG Bulgaria
Listing BSOBGN MKR

About Momina Krepost AD

http://www.mkrepost-bg.com

Momina Krepost AD is a manufacturer specializing in two main product lines: single-use medical devices and plastic goods for industrial and household use. The company's medical portfolio encompasses a wide range of products, including syringes, sterile hypodermic needles, catheters, and various sets intended for application in diverse medical fields such as surgery, urology, intensive therapy, gynecology, gastroenterology, diagnostics, and anesthesiology. Its industrial and household division produces blow-molded and injection-molded plastic items designed for the packaging, storage, and transportation of liquids, chemicals, and other materials. The company serves specialized medical institutions as well as industrial and consumer markets.

Recent filings

Filing Released Lang Actions
685868-signed_Financial_statement 31.03.2026.pdf
Interim / Quarterly Report Classification · 90% confidence The document is titled “Приложение към финансовия отчет към 31 март 2026 година” and contains the actual notes to the financial statements (accounting policies, detailed breakdowns of revenues, expenses, assets, liabilities, risk management, related-party transactions, etc.) for the period ending March 31, 2026. It is clearly part of the interim financial statements for the first quarter rather than an announcement or officer certification. Therefore, it qualifies as a full Interim/Quarterly Report. Q1 2026
2026-04-29 Bulgarian
685875-signed_Допълнителна информация-31.03.26.pdf
Regulatory Filings Classification · 85% confidence The document is titled “Допълнителна информация” (“Additional Information”) prepared under Art. 33(1)(7) of Bulgarian Ordinance No. 2. It provides narrative regulatory disclosures for the quarter ended 31.03.2026 (accounting policy changes, group structure, major shareholdings, legal proceedings, etc.) but does not include full interim financial statements or substantive P&L/balance sheet data. It is a mandatory compliance filing rather than a full interim report or announcement of a report. Thus it falls under general Regulatory Filings (RNS) as a fallback category for miscellaneous mandated disclosures.
2026-04-29 Bulgarian
685874-signed_Вътрешна информация-31.03.26.pdf
Regulatory Filings Classification · 95% confidence The document is a mandatory “Inside Information” disclosure under Bulgarian law and EU Regulation 596/2014 covering facts and circumstances in the first quarter of 2026. It is not a standalone financial report (e.g., annual or interim report), nor is it an earnings release, proxy statement, or other specific category. It serves as a regulatory compliance announcement of significant events and is therefore best classified under the general Regulatory Filings category (RNS).
2026-04-29 Bulgarian
685876-signed_Междинен доклад-31.03.26.pdf
Interim / Quarterly Report Classification · 90% confidence The document is titled “Междинен доклад” covering the first quarter (Q1) of 2026 for Momina Krepost AD, includes substantive financial data (production volumes, revenues, losses), discussion of risks, share capital, and trading data, and explicitly states it is an interim financial report not audited by the auditor. This matches the definition of an Interim/Quarterly Report (Code: IR). Q1 2026
2026-04-29 Bulgarian
685878-signed_Информация Прил.-4-31.03.26.pdf
Regulatory Filings Classification · 90% confidence The document is a mandatory periodic disclosure under Bulgarian Ordinance No.2, listing control changes, insolvency, material contracts, auditor appointment, litigation and other investor-relevant events for the first quarter of 2026. It contains no financial statements or substantive financial data, but rather regulatory updates. This fits the “Regulatory Filings” (RNS) category as a general regulatory announcement rather than a full interim report or other specific category.
2026-04-29 Bulgarian
685877-signed_Декларации по чл.100.pdf
Regulatory Filings Classification · 87% confidence The document is composed of certification declarations under Article 100(o), Paragraph 4, Item 3 of the Bulgarian Capital Markets Act by the Executive Director and the Chief Accountant. They attest to the truthfulness of the Q1 2026 financial statements and interim management report but contain no actual financial data. As primarily officer certifications, under the “Certification Rule” they should be classified as a Regulatory Filing (RNS).
2026-04-29 Bulgarian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.